Menu Search
Equities

Gerresheimer AG

GXIX:GER

Gerresheimer AG

Actions
Health CareMedical Equipment and Services
  • Price (EUR)75.70
  • Today's Change-0.25 / -0.33%
  • Shares traded96.17k
  • 1 Year change-16.86%
  • Beta1.0077
Data delayed at least 15 minutes, as of Nov 08 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy5
Outperform11
Hold3
Sell0
Strong Sell0

Share price forecast in EUR

The 18 analysts offering 12 month price targets for Gerresheimer AG have a median target of 108.50, with a high estimate of 150.00 and a low estimate of 87.00. The median estimate represents a 43.33% increase from the last price of 75.70.
High98.2%150.00
Med43.3%108.50
Low14.9%87.00

Dividends in EUR

In 2023, Gerresheimer AG reported a dividend of 1.25 EUR, equaling last years dividend. The 16 analysts covering the company expect dividends of 1.28 EUR for the upcoming fiscal year, an increase of 2.48%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in EUR

On Oct 10, 2024, Gerresheimer AG reported 3rd quarter 2024 earnings of 1.16 per share. This result was in line with the consensus of the 3 analysts following the company and exceeded last year's 3rd quarter results by 8.41%.
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate+17.12%
Gerresheimer AG reported annual 2023 earnings of 4.62 per share on Feb 22, 2024.
Average growth rate-7.01%
More ▼

Revenue history & estimates in EUR

Gerresheimer AG had 3rd quarter 2024 revenues of 498.50m. This missed the 499.81m consensus estimate of the 5 analysts following the company. This was 8.90% above the prior year's 3rd quarter results.
Average growth rate+1.06%
Gerresheimer AG had revenues for the full year 2023 of 1.99bn. This was 9.54% above the prior year's results.
Average growth rate+9.58%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.